CAN CSA-Z264 2-1999 Labelling of Drug Ampoules Vials and Prefilled Syringes (First Edition General Instruction No 1 January 1999 General Instruction No 2 October 1999).pdf
《CAN CSA-Z264 2-1999 Labelling of Drug Ampoules Vials and Prefilled Syringes (First Edition General Instruction No 1 January 1999 General Instruction No 2 October 1999).pdf》由会员分享,可在线阅读,更多相关《CAN CSA-Z264 2-1999 Labelling of Drug Ampoules Vials and Prefilled Syringes (First Edition General Instruction No 1 January 1999 General Instruction No 2 October 1999).pdf(29页珍藏版)》请在麦多课文档分享上搜索。
1、Z264.2-99(reaffirmed 2014)Labelling of Drug Ampoules, Vials, and Prefilled SyringesLegal Notice for StandardsCanadian Standards Association (operating as “CSA Group”) develops standards through a consensus standards development process approved by the Standards Council of Canada. This process brings
2、 together volunteers representing varied viewpoints and interests to achieve consensus and develop a standard. Although CSA Group administers the process and establishes rules to promote fairness in achieving consensus, it does not independently test, evaluate, or verify the content of standards.Dis
3、claimer and exclusion of liabilityThis document is provided without any representations, warranties, or conditions of any kind, express or implied, including, without limitation, implied warranties or conditions concerning this documents fitness for a particular purpose or use, its merchantability,
4、or its non-infringement of any third partys intellectual property rights. CSA Group does not warrant the accuracy, completeness, or currency of any of the information published in this document. CSA Group makes no representations or warranties regarding this documents compliance with any applicable
5、statute, rule, or regulation. IN NO EVENT SHALL CSA GROUP, ITS VOLUNTEERS, MEMBERS, SUBSIDIARIES, OR AFFILIATED COMPANIES, OR THEIR EMPLOYEES, DIRECTORS, OR OFFICERS, BE LIABLE FOR ANY DIRECT, INDIRECT, OR INCIDENTAL DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES, HOWSOEVER CAUSED, INCLUDING BUT NOT LIMI
6、TED TO SPECIAL OR CONSEQUENTIAL DAMAGES, LOST REVENUE, BUSINESS INTERRUPTION, LOST OR DAMAGED DATA, OR ANY OTHER COMMERCIAL OR ECONOMIC LOSS, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR ANY OTHER THEORY OF LIABILITY, ARISING OUT OF OR RESULTING FROM ACCESS TO OR POSSESSION OR USE OF T
7、HIS DOCUMENT, EVEN IF CSA GROUP HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES.In publishing and making this document available, CSA Group is not undertaking to render professional or other services for or on behalf of any person or entity or to perform any dut
8、y owed by any person or entity to another person or entity. The information in this document is directed to those who have the appropriate degree of experience to use and apply its contents, and CSA Group accepts no responsibility whatsoever arising in any way from any and all use of or reliance on
9、the information contained in this document. CSA Group is a private not-for-profit company that publishes voluntary standards and related documents. CSA Group has no power, nor does it undertake, to enforce compliance with the contents of the standards or other documents it publishes. Intellectual pr
10、operty rights and ownershipAs between CSA Group and the users of this document (whether it be in printed or electronic form), CSA Group is the owner, or the authorized licensee, of all works contained herein that are protected by copyright, all trade-marks (except as otherwise noted to the contrary)
11、, and all inventions and trade secrets that may be contained in this document, whether or not such inventions and trade secrets are protected by patents and applications for patents. Without limitation, the unauthorized use, modification, copying, or disclosure of this document may violate laws that
12、 protect CSA Groups and/or others intellectual property and may give rise to a right in CSA Group and/or others to seek legal redress for such use, modification, copying, or disclosure. To the extent permitted by licence or by law, CSA Group reserves all intellectual property rights in this document
13、.Patent rightsAttention is drawn to the possibility that some of the elements of this standard may be the subject of patent rights. CSA Group shall not be held responsible for identifying any or all such patent rights. Users of this standard are expressly advised that determination of the validity o
14、f any such patent rights is entirely their own responsibility.Authorized use of this documentThis document is being provided by CSA Group for informational and non-commercial use only. The user of this document is authorized to do only the following:If this document is in electronic form:sLOADTHISDO
15、CUMENTONTOACOMPUTERFORTHESOLEPURPOSEOFREVIEWINGITsSEARCHANDBROWSETHISDOCUMENTANDsPRINTTHISDOCUMENTIFITISIN0$ and Cover, title page, and copyright page dated October 1999. Update your copy by inserting these revised pages. 0 Keep the pages you remove for reference. CAN/CSA-Z264.2-99 Labelling of Drug
16、 Ampoules, Vials, and Preplled Syringes A National Standard of Canada (approved October 1999) The Canadian Standards Association, which opemtes under the name CSA International (a), under whose auspices this National Standard has been produced, was chartered in 191 9 and accredited by the Standards
17、Council of Canada to the National Standards system in 1973. It is a not-for-profit, nonstatutory, voluntary membership association engaged in standards development and certification activities. CSA standards reRect a national consensus of producers and users - including manufacturers, consumers, ret
18、ailers, unions and professional organizations, and governmental agencies. The standards are used widely by industry and commerce and often adopted by municipal, provincial, and federal governments in their regulations, partiCula* in the fields of health, safety, building and consttuction, and the en
19、vironment. Individuals, companies, and associations across Canada indicate their support for CSAs standards development by volunteering their time and skills to CSA Committee work and supporting the Associations objectives through sustaining memberships. The more than 7000 committee volunteers and t
20、he 2000 sustaining memberships together form CSAs total membership from which its Directors are chosen. Sustaining memberships represent a major source of income for CSAs standards development activities. the Association regularly and continually audits and inspects products that bear the CSA Mark c
21、ountries. Since 191 9, the Association has developed the necessary expertise to meet its corporate mission: CSA is an independent service organization whose mission is to provide an open and effective forum for activities facilitating the exchange of goods and services through the use of standards,
22、certification and related services to meet national and international needs. LArrociation CaMdienne de nomiagsation, maintenant connue SOUS le nom Intemational (CSA), sous les auspices de laquelle cette Norme nationale a t prpare, a regu ses lettres patentes en 191 9 et son accrditation au sein du S
23、ystme de normes nationales par le Conseil canadien des normes en 1973. Association daffiliation libre, sans but lucratif ni pouvoir de rglementation, elle se consacre llaboration de normes et la ceitification. Les normes CSA refltent le consensus de producteurs et dusagers de partout au pays, au nom
24、bre desquels se trouvent des fabricants, des consommateurs, des dtaillants et des reprsentants de syndicab, de corps professionnels et dagences gouvernementales. Lutilisation des normes CSA est trs rpandue dans lindustrie et le commerce, et leur adoption divers ordres de lgislation, tant municipal e
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
10000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- CANCSAZ26421999LABELLINGOFDRUGAMPOULESVIALSANDPREFILLEDSYRINGESFIRSTEDITIONGENERALINSTRUCTIONNO1JANUARY1999GENERALINSTRUCTIONNO2OCTOBER1999PDF

链接地址:http://www.mydoc123.com/p-591345.html